Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma. (Q53537025)
Jump to navigation
Jump to search
scientific article published in September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma. |
scientific article published in September 2007 |
Statements
Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma. (English)
1 reference
Stephen A Boorjian
1 reference
Matthew I Milowsky
1 reference
Jodi Kaplan
1 reference
Martin Albert
1 reference
Marta Vallee Cobham
1 reference
Deirdre M Coll
1 reference
Gary Shelton
1 reference
Daniel Petrylak
1 reference
Lorraine J Gudas
1 reference
David M Nanus
1 reference
1 September 2007
1 reference
30
1 reference
6
1 reference
655-662
1 reference
Identifiers
1 reference